The FDA gives the green light to the first gene therapy for deafness
NPR
—
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness.
But it represents a medical milestone.
Regeneron inks drug price deal
- Trump promotes new drug price deal with Regeneron UPI —
- WATCH: Trump unveils deal with Regeneron to lower its drug prices for Medicaid PBS —
- Trump announces Regeneron deal to lower drug prices 📹 C-SPAN —
- Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free CNBC —
- Regeneron Shares Up on Trump Drug Pricing Deal Barrons —